Benchmark indices are expected to witness stock-specific action today as investors react to quarterly earnings, strategic acquisitions, project wins and regulatory developments announced by several listed companies.
Market participants will closely monitor corporate earnings, infrastructure contracts, stake sales, acquisitions and business expansion initiatives, which could influence sentiment during today's trading session.
HCL Technologies reported a strong set of first-quarter results. Consolidated net profit rose 20.3% year-on-year to ₹4,624 crore, while revenue increased 13.9% to ₹34,579 crore. EBIT climbed 18% to ₹5,831 crore, with the EBIT margin improving to 16.86% from 16.28%. The company's board also declared an interim dividend of ₹12 per share for FY27.
ICICI Prudential Asset Management Company posted a healthy quarterly performance, with net profit rising 23.1% year-on-year to ₹964.6 crore. Revenue grew 17.6% to ₹1,564.2 crore, reflecting continued strength in its asset management business.
Biocon will remain in focus after reports indicated that Mylan Inc is likely to sell its entire 5.64% stake through block deals, with a floor price of ₹378.50 per share. Investors will watch the transaction and its potential impact on the stock.
Timken India received Bureau of Indian Standards (BIS) licences for two product categories across two manufacturing facilities, strengthening its manufacturing capabilities and product compliance.
EMS emerged as the lowest bidder for a sewerage project worth ₹105.81 crore awarded by UP Jal Nigam (Urban), Varanasi. The order is expected to support the company's infrastructure order book.
The US Food and Drug Administration (USFDA) issued a warning letter to a Clinical Investigator associated with a bioequivalence study conducted at the Alembic Pharmaceuticals facility. The observations relate to the Informed Consent Form process and do not concern data integrity.
Welspun Enterprises' subsidiary, Welspun Pune Shirur Projects, signed a sub-concession agreement with the Maharashtra State Infrastructure Development Corporation and the Government of Maharashtra for the Pune-Shirur highway project valued at ₹7,300 crore.
Read More: India's Exports Rise 15.5% in June 2026, Trade Deficit Widens to $30.43 Billion!
Emcure Pharmaceuticals signed share transfer agreements to acquire the remaining 12.05% stake in Gennova Biopharmaceuticals for ₹231.87 crore. Following completion of the acquisition, Gennova will become a wholly-owned subsidiary of the company.
PDS entered into a Sourcing as a Service (SaaS) agreement with the global sourcing division of a leading French-headquartered supermarket group. The contract covers textile sourcing operations across Bangladesh, Pakistan, India, Sri Lanka and Turkey.
Grasim Industries announced that its subsidiary, Aditya Birla Renewables, approved the acquisition of 100% stake in Solenergi Power Private Limited from Shell Overseas Investment BV for ₹17,200 crore. The acquisition will strengthen the group's renewable energy portfolio through ownership of Sprng Energy and Sprng Solar Plus.
Nuvoco Vistas reported a solid quarterly performance, with net profit rising 20% year-on-year to ₹159.8 crore, while revenue increased 8.9% to ₹3,128.7 crore.
Augusta TBO (Singapore) Pte reduced its holding in TBO Tek by selling a 2.04% stake through open market transactions, lowering its shareholding to 3.5%.
Butterfly Gandhimathi Appliances secured a patent for its invention titled "Improvised Safety Knob for Gas Cooktops", which will remain valid for 20 years with effect from December 29, 2021.
Quarterly earnings, stake sales, infrastructure project wins, acquisitions and regulatory developments are expected to drive stock-specific movements in today's trading session, keeping several sectors under investor focus.
Want to track these market movements in Hindi? Visit Angel One News for daily updates and comprehensive share market news in Hindi.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks. Read all related documents carefully before investing.
Published on: Jul 14, 2026, 8:21 AM IST
Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
EN